Retrospective Study
Copyright ©The Author(s) 2023.
World J Transplant. Dec 18, 2023; 13(6): 344-356
Published online Dec 18, 2023. doi: 10.5500/wjt.v13.i6.344
Figure 1
Figure 1 Median age across various cohorts.
Figure 2
Figure 2 Intra-group age analysis A1 vs A2.
Figure 3
Figure 3 Age-related survival probability.
Figure 4
Figure 4 Ethnicity across various cohorts.
Figure 5
Figure 5 Survival probability with age and ethnicity.
Figure 6
Figure 6 Diabetic status across various cohorts.
Figure 7
Figure 7 Survival probability with age and diabetic status.
Figure 8
Figure 8 Body mass index range across various cohorts. BMI: Body mass index; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 9
Figure 9 Median estimated glomerular filtration rate across various cohorts. eGFR: Estimated glomerular filtration rate; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 10
Figure 10  Survival probability dependent on graft estimated glomerular filtration rate. eGFR: Estimated glomerular filtration rate.
Figure 11
Figure 11  Albumin (g/L) across various cohorts. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 12
Figure 12  Hb distribution among various cohorts. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 13
Figure 13  Serum Ca distribution across various cohorts. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 14
Figure 14  Comparison of current study demographics with published data. IHD: Ischemic heart disease; DM: Diabetes mellitus; BMI: Body mass index.
Figure 15
Figure 15  Comparison of current study routine lab parameters with published data. eGFR: Estimated glomerular filtration rate.
Figure 16
Figure 16  Multiple logistic regression: Mortality with Haemoglobin, Estimated glomerular filtration rate, Albumin and Ca.